Paid Clinical Trials in Uniondale, NY
As of September 2026, 222 paid clinical trials are recruiting in Uniondale, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Uniondale offers studies at sites including Memorial Sloan Kettering Nassau (Limited Protocol Activities) for conditions such as Breast Cancer, Multiple Myeloma, Prostate Cancer, Acute Myeloid Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Uniondale
Trials by drug in Uniondale
Filter results
Newly added in Uniondale
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease
A Study of Armored CAR T Cells in People With Cancer
A Study of Romosozumab in People With Breast Cancer and Osteoporosis
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
218 clinical trials
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
A Study of Lung Cancer Risk
A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Malignant Polyp Registry
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
A Dietary Study for People With Clonal Hematopoiesis
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
Registry for Bone Metastases
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Top Research Study Locations in Uniondale
Researchers run research studies in Uniondale, NY at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Breast Cancer, Multiple Myeloma, Metastatic Breast Cancer | 69 |
| Memorial Sloan Kettering Nassau | Acute Myeloid Leukemia, Breast Cancer, Stage IV Lung Cancer AJCC v8 | 66 |
| Memorial Sloan Kettering Nassau (All Protocol Activities) | Non-Small Cell Lung Cancer, Breast Cancer, Monoclonal Gammopathy of Undetermined Significance | 35 |
| Memorial Sloan Kettering Nassau (Consent Only) | Breast Cancer, Pancreatic Cancer, Prostate Cancer | 19 |
| Memorial Sloan Kettering at Nassau (Limited Protocol Activities) | Breast Cancer, Prostate Cancer, Adenocarcinoma of the Breast | 12 |
| MSK Nassau | Multiple Myeloma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 6 |
| Memorial Sloan Kettering Cancer Center @ Nassau (Consent only) | Crystalline Lens; Chalcosis, GVHD, Graft-Versus-Host Disease | 4 |
| Memorial Sloan Kettering Cancer Center @ Nassau (Limited Protocol Activities) | Advanced Solid Tumor, Metastatic Solid Tumor, Neuroendocrine Cancer | 2 |
| Memorial Sloan Kettering Nassau - Limited Protocol Activities | Clinical Stage: Stage II (T3-4, N-), Intrahepatic Cholangiocarcinoma, Rectal Adenocarcinoma | 2 |
| MSK Nassau. | Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC) | 1 |
| Memorial Sloan Kettering (Nassau) | Cervical Cancer | 1 |
| Memorial Sloan Kettering Cancer Center - Nassau | Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations | 1 |
| Memorial Sloan Kettering Cancer Center Nassau | Locally Advanced Breast Cancer, Metastatic Breast Cancer, Unresectable Breast Carcinoma | 1 |
| Memorial Sloan Kettering Nassau (Consent and Follow-Up) | Renal Cancer | 1 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activity) | APC Gene Mutation, ATM Gene Mutation, BARD1 Gene Mutation | 1 |
| Memorial Sloan Kettering at Nassau (Consent and Followup) | Bone Neoplasm, Bone Sarcoma, Chondrosarcoma | 1 |
Active & Upcoming Studies in Uniondale (2026)
Recruiting trials in Uniondale grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (182 active studies)
- A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment · Phase 2 · Alliance for Clinical Trials in Oncology
- A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma · Phase 1 · Memorial Sloan Kettering Cancer Center
Mental health & behavior (1 active study)
- A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home · Memorial Sloan Kettering Cancer Center
Diabetes & metabolic (1 active study)
- A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer · Phase 1 · Memorial Sloan Kettering Cancer Center
Neurology & pain (1 active study)
- A Study of Stereotactic Radiosurgery (SRS) to Treat Pain in the Chest and/or Stomach Wall · Phase 1 · Memorial Sloan Kettering Cancer Center
Pediatric (1 active study)
- A Study of 177Lu-PSMA-617 in People With Gliomas · Phase 1 · Memorial Sloan Kettering Cancer Center
Common conditions studied in Uniondale
- Breast Cancer (18 active studies)
- Multiple Myeloma (11 active studies)
- Prostate Cancer (7 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Metastatic Breast Cancer (6 active studies)
- Non-Small Cell Lung Cancer (6 active studies)
Leading research sponsors in Uniondale
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Pfizer
Frequently asked questions
How many paid clinical trials are currently recruiting in Uniondale?
There are approximately 222 recruiting clinical trials in Uniondale, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Uniondale pay participants?
Most recruiting trials in Uniondale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Uniondale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Uniondale?
The most common conditions under active study in Uniondale include Breast Cancer (18), Multiple Myeloma (11), Prostate Cancer (7), Acute Myeloid Leukemia (6), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Uniondale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Uniondale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Uniondale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Uniondale?
Recruiting research sites in Uniondale include Memorial Sloan Kettering Nassau (Limited Protocol Activities), Memorial Sloan Kettering Nassau, Memorial Sloan Kettering Nassau (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Uniondale right now?
The largest active categories in Uniondale are Cancer & tumors (182), Mental health & behavior (1), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.